Matthewb Klein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Matthewb klein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Matthewb Klein Today - Breaking & Trending Today

PTC Therapeutics, Inc. (NASDAQ:PTCT) Given Average Rating of "Hold" by Brokerages

Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) have been given an average rating of “Hold” by the fourteen analysts that are covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and four have issued a buy recommendation on […] ....

United States , Raymond James , Matthewb Klein , Jeromeb Zeldis , Charles Schwab Investment Management Inc , Vise Technologies Inc , Jefferies Financial Group , Goldman Sachs Group , Therapeutics Inc , Rathbones Group , Therapeutics Company Profile , Walleye Capital , Securities Exchange Commission , Get Free Report , Financial Group , Exchange Commission , Director Jerome , Schwab Investment Management , Get Free ,

PTC Therapeutics (NASDAQ:PTCT) Given New $53.00 Price Target at JPMorgan Chase & Co.

PTC Therapeutics (NASDAQ:PTCT – Free Report) had its target price hoisted by JPMorgan Chase & Co. from $43.00 to $53.00 in a research report released on Tuesday morning, Benzinga reports. They currently have an overweight rating on the biopharmaceutical company’s stock. A number of other brokerages also recently weighed in on PTCT. Cantor Fitzgerald reissued […] ....

United States , Jeromeb Zeldis , Raymond James , Matthewb Klein , Jpmorgan Chase Co , Jefferies Financial Group , Hexagon Capital Partners , Therapeutics Company Profile , Morgan Stanley , Therapeutics Inc , Allspring Global Investments Holdings , Cantor Fitzgerald , Goldman Sachs Group , Free Report , Get Free Report , Director Jerome , Capital Partners , Global Investments Holdings , Retirement System , Rhumbline Advisers ,

PTC Therapeutics, Inc. (NASDAQ:PTCT) Expected to Earn Q2 2024 Earnings of ($1.02) Per Share

PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) – Research analysts at Leerink Partnrs dropped their Q2 2024 earnings per share estimates for shares of PTC Therapeutics in a report issued on Sunday, May 19th. Leerink Partnrs analyst J. Schwartz now forecasts that the biopharmaceutical company will earn ($1.02) per share for the quarter, down from […] ....

United States , Leerink Partnrs , Matthewb Klein , Raymond James , Therapeutics Inc , Headlands Technologies , Royal Bank , Allspring Global Investments Holdings , Morgan Stanley , Lazard Asset Management , Therapeutics Company Profile , Ptc Therapeutics Inc , Nisa Investment Advisors , Securities Exchange Commission , Hexagon Capital Partners , Jefferies Financial Group , Free Report , Get Free Report , Financial Group , Trading Down , Capital Partners , Global Investments Holdings , Investment Advisors , Asset Management , Exchange Commission ,